Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity.
Yang C, Jin J, Yang Y, Sun H, Wu L, Shen M, Hong X, Li W, Lu L, Cao D, Wang X, Sun J, Ye Y, Su B, Deng L.
Yang C, et al. Among authors: sun j, sun h.
Immunity. 2022 Jul 12;55(7):1268-1283.e9. doi: 10.1016/j.immuni.2022.05.012. Epub 2022 Jun 13.
Immunity. 2022.
PMID: 35700739
Free article.